---
title: "Vyome Holdings, Inc. Reports Positive Phase 2 Results for VT-1953"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275890596.md"
description: "Vyome Holdings, Inc. reported positive Phase 2 results for VT-1953 on February 12, 2026. The treatment for malignant fungating wounds demonstrated a significant reduction in malodor by Day 14 (P=0.002), with patients experiencing improved quality of life and reduced lesion pain. No adverse effects were noted, supporting the advancement of VT-1953 to pivotal studies. An orphan drug designation application for VT-1953 has also been filed."
datetime: "2026-02-13T11:13:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275890596.md)
  - [en](https://longbridge.com/en/news/275890596.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275890596.md)
---

# Vyome Holdings, Inc. Reports Positive Phase 2 Results for VT-1953

**On February 12, 2026, Vyome Holdings, Inc. announced significant improvements in treating malignant fungating wounds with VT-1953.**

**Key Highlights:**

-   VT-1953 showed significant reduction in malodor by Day 14 (P=0.002).
-   Patients reported improved quality of life and reduced lesion pain.
-   No adverse effects or safety signals were observed during the study.
-   Results support advancing VT-1953 to pivotal studies for MFW treatment.
-   Orphan drug designation application for VT-1953 has been filed.

Original SEC Filing: Vyome Holdings, Inc \[ HIND \] - 8-K - Feb. 12, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [HIND.US](https://longbridge.com/en/quote/HIND.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [Novo Nordisk's stock rallies after drugmaker reveals deal with OpenAI](https://longbridge.com/en/news/282698267.md)
- [Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Data](https://longbridge.com/en/news/284232599.md)
- [Erasca Shares Phase 1 ERAS-0015 Data: 62% NSCLC Response, ctDNA Clearance Signals](https://longbridge.com/en/news/284275878.md)